[go: up one dir, main page]

HN2001000246A - (7-(3-carboxifenil)-4-cloroisoquinolin -1 - il) guanidina. - Google Patents

(7-(3-carboxifenil)-4-cloroisoquinolin -1 - il) guanidina.

Info

Publication number
HN2001000246A
HN2001000246A HN2001000246A HN2001000246A HN2001000246A HN 2001000246 A HN2001000246 A HN 2001000246A HN 2001000246 A HN2001000246 A HN 2001000246A HN 2001000246 A HN2001000246 A HN 2001000246A HN 2001000246 A HN2001000246 A HN 2001000246A
Authority
HN
Honduras
Prior art keywords
carboxifenil
guanidine
chloroisoquinolin
same
chloroisoqquinolin
Prior art date
Application number
HN2001000246A
Other languages
English (en)
Inventor
Anne Bruckner
Michael Butters
Paul Vincent Fish
Michael Paul Fitzgerald
Julie Ann Macrae
Trevor Jack Newbury
Richard Anthony Storey
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of HN2001000246A publication Critical patent/HN2001000246A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A UN PROCEDIMIENTO PARA LA PREPARACION DE (7 - (3 -CARBOXIFENIL) - 4 - CLOROISOQQUINOLIN - 1 - IL) GUANIDINA (I), INTERMEDIOS PARA EL MISMO Y NUEVAS FORMAS Y FORMULACIONES DEL MISMO ADECUADAS PARA EL USO FARMACEUTICO.
HN2001000246A 2000-10-30 2001-10-26 (7-(3-carboxifenil)-4-cloroisoquinolin -1 - il) guanidina. HN2001000246A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0026490.3A GB0026490D0 (en) 2000-10-30 2000-10-30 Process

Publications (1)

Publication Number Publication Date
HN2001000246A true HN2001000246A (es) 2002-05-08

Family

ID=9902194

Family Applications (1)

Application Number Title Priority Date Filing Date
HN2001000246A HN2001000246A (es) 2000-10-30 2001-10-26 (7-(3-carboxifenil)-4-cloroisoquinolin -1 - il) guanidina.

Country Status (16)

Country Link
US (1) US6645979B2 (es)
EP (1) EP1330439A1 (es)
JP (1) JP2004513119A (es)
AP (1) AP2001002320A0 (es)
AU (1) AU2002210820A1 (es)
BR (1) BR0114330A (es)
CA (1) CA2427613A1 (es)
GB (1) GB0026490D0 (es)
HN (1) HN2001000246A (es)
MX (1) MXPA03003928A (es)
PA (1) PA8528801A1 (es)
PE (1) PE20020517A1 (es)
SV (1) SV2003000707A (es)
TN (1) TNSN01152A1 (es)
UY (1) UY26986A1 (es)
WO (1) WO2002036571A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7268058B2 (en) * 2004-01-16 2007-09-11 Intel Corporation Tri-gate transistors and methods to fabricate same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE207479T1 (de) * 1992-01-31 2001-11-15 Chugai Pharmaceutical Co Ltd Kristalle von derivaten von chinozon carbonsäure- hydraten
EP0629631B1 (en) 1993-06-07 2002-08-28 Mitsui Chemicals, Inc. Novel transition metal compound, and polymerization catalyst containing it
GB9721964D0 (en) * 1997-10-16 1997-12-17 Pfizer Ltd Isoquinolines

Also Published As

Publication number Publication date
BR0114330A (pt) 2003-08-26
PE20020517A1 (es) 2002-06-20
MXPA03003928A (es) 2003-08-19
WO2002036571A1 (en) 2002-05-10
US20020077336A1 (en) 2002-06-20
CA2427613A1 (en) 2002-05-10
AU2002210820A1 (en) 2002-05-15
TNSN01152A1 (en) 2005-11-10
SV2003000707A (es) 2003-01-13
PA8528801A1 (es) 2002-08-26
GB0026490D0 (en) 2000-12-13
US6645979B2 (en) 2003-11-11
JP2004513119A (ja) 2004-04-30
UY26986A1 (es) 2002-06-20
AP2001002320A0 (en) 2001-12-31
EP1330439A1 (en) 2003-07-30

Similar Documents

Publication Publication Date Title
HN2001000027A (es) Derivados de purina
HN2003000054A (es) Formas de dosificacion farmaceutica de liberacion controlada de un inhibidor de la proteina de transferencia de ester de colesterilo (cetpi), a procedimientos de uso y a procedimientos de preparacion de las mismas.
ECSP045491A (es) Nueva sal formiato de o-desmetil venlafaxina
UY27740A1 (es) Nuevos compuestos
AR037109A1 (es) Uso de flibanserina
HN1999000124A (es) Derivados de pirazol substituido.
UY28342A1 (es) Nuevos compuestos
PA8551001A1 (es) Nuevos compuestos
HN2001000190A (es) Formulaciones de liberacion sostenida para secretagogos de hormona del crecimiento
HN2004000538A (es) "PIRIDO[ 2,3-d ] PIRIMIDINA-2,4-DIAMINAS COMO-INHIBIDORES DE PDE 2"
HN2001000006A (es) Antagonistas del factor liberador de corticotropina
HN2002000300A (es) Nuevos derivados de piperazina
HN2004000319A (es) "{ 1,8}naftiridin-2-onas y compuestos relacionados para el tratamiento de la esquizofrenia"
HN2003000285A (es) Nuevas quinazolinonas espirocondensadas y su uso como inhibidores de la fosfodiesterasa
BRPI0417717A (pt) composto, composição farmacêutica, e, uso de um composto
ES2161085T3 (es) Formulaciones que contienen oxaliplatino.
UY27455A1 (es) Derivados n-(1,4,5,6-tetrahidro-ciclopentapirazol -3-il)- sustituidos. su obtención y uso como fármacos.
CR8357A (es) Derivados de tetrahidronaftaleno, procedimiento para su preparacion y su uso como antiinflamatorio
GT200500363A (es) 3-amino-pirazol [3,4b] piridinas con inhibidores de proteintirosinquinasas, su preparacion y uso como medicamento.
AR040130A1 (es) Esteres de etonogestrel, su uso como anticopceptivo y para el tratamiento de desordenes ginecologicos
ECSP034754A (es) Derivados de beta-carbolina y su uso farmaceutico contra depresion y ansiedad
AR030662A1 (es) Beta-tio-alfa-aminoacidos, procedimiento para su fabricacion, medicamentos que contienen estos compuestos y el uso de los tioaminoacidos para la preparacion de medicamentos
ECSP034532A (es) Derivados del 1-aminobutan-3-ol sustituido
HN2000000056A (es) Nuevas formas cristalinas de un antibiotico macrolido
HN2001000246A (es) (7-(3-carboxifenil)-4-cloroisoquinolin -1 - il) guanidina.